Conceptrichtlijn colorectaal carcinoom 2013 - Oncoline

63516352635363546355635663576358635963606361636263636364636563666367636863696370637163726373637463756376637763786379638063816382638363846385638663876388638963906391639263936394639563966397639863996400640164026403da Luz Moreira A, Kiran RP, Kirat HT, Remzi FH, Geisler DP, Church JM, et al. Laparoscopic versus opencolectomy for patients with American Society of Anesthesiology (ASA) classifications 3 and 4: the minimallyinvasive approach is associated with significantly quicker recovery and reduced costs. Surg Endosc. 2010Jun;24(6):1280-6. doi: 10.1007/s00464-009-0761-3. Epub 2009 Dec 24.Dafnis G, Granath F, Pahlman L, Ekbom A, Blomqvist P. Patient factors influencing the completion rate incolonoscopy. Dig Liver Dis 2005;37:113-8.Daniels IR, Strassburg J, Moran BJ. The need for future surgical low rectal cancer studies. Colorectal Dis 2006; 8Suppl 3:25-29.Davila RE, Rajan E, Adler D, Hirota WK, Jacobson BC, Leighton JA, et al. ASGE guideline: the role ofendoscopy in the diagnosis, staging, and management of colorectal cancer. Gastrointestinal endoscopy. 2005Jan;61(1):1-7.Dawson LA, McGinn CJ, Normolle D, et al. Escalated focal liver radiation and concurrent hepatic arteryfluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 2000 Jun;18(11):2210-8.de Baere T, Roche A, Elias D, Lasser P, Lagrange C, Bousson V. Preoperative portal vein embolization forextension of hepatectomy indications. Hepatology 1996;24:1386-1391.Decadt B, Siriwardena AK. Radiofrequency ablation of liver tumours: systematic review. Lancet Oncol2004;5:550-560.Deepak Hariharan et al. The role of laparoscopy and laparoscopic ultrasound in the preoperative staging ofpatients with resectable colorectal liver metastases: a meta-analysis.The American Journal of Surgery (2012)204, 84–92.De Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-linetreatment in advanced colorectal cancer. J Clin Oncol 2000;18:2938-2947.de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J et al. Leucovorin and fluorouracil with orwithout oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 2000;18:2938-47.De Gramont A, Boni C, Navarro M, Tabernero J, Hickish T, Topham C et al. Oxaliplatin/5FU/LV in the adjuvanttreatment of stage II and stage III colon cancer: efficacy results with a median follow-up of 4 years. J Clin Oncol.2005 ASCO Annual Meeting Proceedings. Vol 23, No. 16S, Part I of II (June 1 Supplement), 2005:3501.de Gramont A, Buyse M, Abrahantes JC, et al. Reintroduction of oxaliplatin is associated with improved survivalin advanced colorectal cancer. J Clin Oncol 2007;25:3224-9.de Gramont A, Hubbard J, Shi Q, O'Connell MJ, Buyse M, Benedetti J, et al. Association between disease-freesurvival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvanttherapy for colon cancer: simulations based on the 20,800 patient ACCENT data set. Clin Oncol. 2010 Jan20;28(3):460-5. doi: 0.1200/JCO.2009.23.1407. Epub 2009 Dec 14.de Gramont A, Van Cutsem E, Schmoll HJ, Tabernero J, Clarke S, Moore MJ, et al. Bevacizumab plusoxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomisedcontrolled trial. Lancet Oncol. 2012 Dec;13(12):1225-33. doi: 10.1016/S1470-2045(12)70509-0. Epub 2012 Nov16.de Miguel M, Oteiza F, et al. Sacral nerve stimulation for the treatment of faecal incontinence following lowanterior resection for rectal cancer. Colorectal Dis 2010 13(1): 72-77.Richtlijn Colorectaal carcinoom en Colorectale levermetastasen 2013 - CONCEPT 153